Trial · NCT04688775
Participant flow32
How many started, completed or left each group, period by period.
1 to 20 of 32
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Placebo-controlled Period | STARTED | Eptinezumab | 113 | |
| Placebo-controlled Period | STARTED | Placebo | 118 | |
| Placebo-controlled Period | STARTED | Delayed Start Period: Placebo to Eptinezumab | 0 | |
| Placebo-controlled Period | STARTED | Delayed Start Period: Eptinezumab to Placebo | 0 | |
| Placebo-controlled Period | Received at Least 1 Dose of Study Drug | Eptinezumab | 112 | |
| Placebo-controlled Period | Received at Least 1 Dose of Study Drug | Placebo | 117 | |
| Placebo-controlled Period | Received at Least 1 Dose of Study Drug | Delayed Start Period: Placebo to Eptinezumab | 0 | |
| Placebo-controlled Period | Received at Least 1 Dose of Study Drug | Delayed Start Period: Eptinezumab to Placebo | 0 | |
| Placebo-controlled Period | COMPLETED | Eptinezumab | 108 | |
| Placebo-controlled Period | COMPLETED | Placebo | 107 | |
| Placebo-controlled Period | COMPLETED | Delayed Start Period: Placebo to Eptinezumab | 0 | |
| Placebo-controlled Period | COMPLETED | Delayed Start Period: Eptinezumab to Placebo | 0 | |
| Placebo-controlled Period | NOT COMPLETED | Eptinezumab | 5 | |
| Placebo-controlled Period | NOT COMPLETED | Placebo | 11 | |
| Placebo-controlled Period | NOT COMPLETED | Delayed Start Period: Placebo to Eptinezumab | 0 | |
| Placebo-controlled Period | NOT COMPLETED | Delayed Start Period: Eptinezumab to Placebo | 0 | |
| Delayed Start Period | STARTED | Eptinezumab | 0 | |
| Delayed Start Period | STARTED | Placebo | 0 | |
| Delayed Start Period | STARTED | Delayed Start Period: Placebo to Eptinezumab | 107 | |
| Delayed Start Period | STARTED | Delayed Start Period: Eptinezumab to Placebo | 108 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04688775/flow